For PE, VC, and Investors — Know What You're Backing

A great pitch deck doesn't mean great science. We provide life sciences due diligence for private equity firms, venture capital, and strategic investors — digging into the technology, the IP, the regulatory path, and the competitive landscape so you invest based on evidence, not enthusiasm.

Competitive Intelligence

We map out who's doing what in your target space — the real players, the emerging threats, and the white space. So you can spot high-potential deals and steer clear of crowded or overhyped areas.

Market Analysis

We give you the numbers that matter: market size, growth trajectory, demand drivers, and commercial viability. Tailored to biotech and healthcare, backed by data — not optimism.

Regulatory & IP Review

We assess the full IP landscape — patents, freedom to operate, competitive positioning — alongside regulatory compliance. You'll know exactly where the risks are before they become expensive surprises.

Expert & KOL Network

Sometimes you need to hear it from someone who's spent 20 years in the field. We connect you with KOLs and domain specialists who can give you an unbiased read on whether the science actually holds up.

Regulatory Navigation

FDA, EMA, and everything in between. We build realistic approval pathways and flag where delays typically happen — so your timeline isn't built on wishful thinking.

Technology Assessment

We evaluate the science on its own terms: innovation potential, feasibility, scalability, and technical risk. Whether you're a private equity fund or a family office, this is where we tell you what the technology is actually worth — not what the founders hope it's worth.

Budget & Financial Strategy

Focused on the balance sheet health angle. "Is this company's financial foundation as solid as their pitch?"

Competitive Intelligence — Who else is in the space, and where's the real opportunity.

Market Analysis — Honest sizing, trends, and demand signals — not inflated TAM slides.

Regulatory & IP Review — Patents, freedom to operate, and compliance risks mapped out clearly.

Expert & KOL Network — Direct access to scientists and clinicians who can validate the science.

Regulatory Navigation — Realistic FDA/EMA timelines and approval strategies.

Technology Assessment — Is it sound? Can it scale? We answer what the deck doesn't.

We bring lab-level understanding to your investment process. Not just reports — real analysis, honest answers, and connections to funding-ready startups in our network.